Zoetis Inc. vs Johnson & Johnson
ZTS vs JNJ — side-by-side comparison from reported financials. ZTS leads 6, JNJ leads 4 of 10 comparable metrics.
Zoetis Inc.
ZTS · Healthcare
$73.90+1.12%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | ZTS | JNJ |
|---|---|---|
| Price | $73.90 | $261.79 |
| Market cap | $30.5B | $631B |
| Revenue (TTM) | $9.52B | $97.9B |
| Revenue growth | +5.4% | +5.6% |
| Net margin | 27.5% | 21.5% |
| Free cash flow | $2.37B | $22.2B |
| Net cash (debt) | ($6.73B) | ($27.8B) |
| 1-year price return | -48.5% | +37.0% |
| P/E | 11.8 | 29.9 |
| P/E vs own history (cheap-side %) | 97% | 16% |
| Dividend yield | 2.89% | 2.00% |
| Return on equity | 69% | 26% |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 14,500 | 140,800 |
Full résumé-style profiles: ZTS CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.